252 related articles for article (PubMed ID: 32361310)
41. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.
Fontaine V; Duboscq-Bidot L; Jouve C; Hamlin M; Curjol A; Briand V; Janiak P; Hulot JS; Pruniaux-Harnist MP; Charron P; Villard E
Stem Cell Res; 2021 Apr; 52():102245. PubMed ID: 33610018
[TBL] [Abstract][Full Text] [Related]
42. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
[TBL] [Abstract][Full Text] [Related]
43. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
[TBL] [Abstract][Full Text] [Related]
44. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
45. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia.
Okada H; Nakanishi C; Yoshida S; Shimojima M; Yokawa J; Mori M; Tada H; Yoshimuta T; Hayashi K; Yamano T; Hanayama R; Yamagishi M; Kawashiri MA
Sci Rep; 2019 Mar; 9(1):4695. PubMed ID: 30886174
[TBL] [Abstract][Full Text] [Related]
46. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
[TBL] [Abstract][Full Text] [Related]
47. Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout human embryonic stem cell line.
Zhang C; Wei Y; Zhang Y; Zhang J; Xing Q; Zhou M; Shan Y
Stem Cell Res; 2021 Apr; 52():102234. PubMed ID: 33607472
[TBL] [Abstract][Full Text] [Related]
48. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Ben Jehuda R; Shemer Y; Binah O
Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
[TBL] [Abstract][Full Text] [Related]
49. CRISPR/Cas9 and
Muto V; Benigni F; Magliocca V; Borghi R; Flex E; Pallottini V; Rosa A; Compagnucci C; Tartaglia M
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175696
[TBL] [Abstract][Full Text] [Related]
50. Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction.
Hagan M; Ashraf M; Kim IM; Weintraub NL; Tang Y
Med Hypotheses; 2018 Jan; 110():97-100. PubMed ID: 29317080
[TBL] [Abstract][Full Text] [Related]
51. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
52. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A).
Kayser A; Dittmann S; Hamidi J; Laufer SD; Krampe R; Mearini G; Hansen A; Schulze-Bahr E
Stem Cell Res; 2024 Aug; 78():103446. PubMed ID: 38776645
[TBL] [Abstract][Full Text] [Related]
53. Human iPSC lines from a Christianson syndrome patient with NHE6 W523X mutation, a biologically-related control, and CRISPR/Cas9 gene-corrected isogenic controls.
Ma L; Schmidt M; Morrow EM
Stem Cell Res; 2021 Jul; 54():102435. PubMed ID: 34182254
[TBL] [Abstract][Full Text] [Related]
54. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
55. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9.
Pavlinov I; Farkhondeh A; Yang S; Xu M; Cheng YS; Beers J; Zou J; Liu C; Might M; Rodems S; Baumgärtel K; Zheng W
Stem Cell Res; 2021 Oct; 56():102554. PubMed ID: 34619643
[TBL] [Abstract][Full Text] [Related]
56. CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.
Gabr H; El Ghamrawy MK; Almaeen AH; Abdelhafiz AS; Hassan AOS; El Sissy MH
Stem Cell Res Ther; 2020 Sep; 11(1):390. PubMed ID: 32912325
[TBL] [Abstract][Full Text] [Related]
57. Generation of FOS gene knockout lines from a human embryonic stem cell line using CRISPR/Cas9.
Li C; Wang Q; Peng Z; Lin Y; Liu H; Yang X; Li S; Liu X; Chen J
Stem Cell Res; 2019 Aug; 39():101479. PubMed ID: 31229900
[TBL] [Abstract][Full Text] [Related]
58. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
[TBL] [Abstract][Full Text] [Related]
59. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
Feng H; Li Q; Margolis RL; Li PP
Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
[TBL] [Abstract][Full Text] [Related]
60. Generation of a homozygous CRISPR/Cas9-mediated knockout H9 hESC subline for the MERTK locus.
Tang X; Fu J; Chen Z; Luo L; Li DW; Liu Y
Stem Cell Res; 2021 May; 53():102310. PubMed ID: 33812335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
